PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24516629-0	2014	The neurogenic effects of exogenous neuropeptide Y: early molecular events and long-lasting effects in the hippocampus of trimethyltin-treated rats.	trimethyltin	122-134	neuropeptide Y	Rattus norvegicus	36-50	
12413652-0	2002	Neuropeptide Y and somatostatin participate differently in the seizure-generating mechanisms following trimethyltin-induced hippocampal damage.	trimethyltin	103-115	neuropeptide Y	Rattus norvegicus	0-14	
9831121-0	1998	Trimethyltin-induced expression of neuropeptide Y Y2 receptors in rat dentate gyrus.	trimethyltin	0-12	neuropeptide Y	Rattus norvegicus	35-49	
9831121-1	1998	Trimethyltin (TMT) causes prominent neuronal damage and enhanced expression of neuropeptide Y in the hippocampus.	trimethyltin	0-12	neuropeptide Y	Rattus norvegicus	79-93	
9831121-1	1998	Trimethyltin (TMT) causes prominent neuronal damage and enhanced expression of neuropeptide Y in the hippocampus.	trimethyltin	14-17	neuropeptide Y	Rattus norvegicus	79-93	
24516629-2	2014	In the rat model of hippocampal neurodegeneration obtained by Trimethyltin (TMT) administration (8 mg/kg), characterised by selective pyramidal cell loss, enhanced neurogenesis, seizures and cognitive impairment, we previously demonstrated a proliferative role of exogenous neuropeptide Y (NPY), on dentate progenitors in the early phases of neurodegeneration.	trimethyltin	62-74	neuropeptide Y	Rattus norvegicus	274-288	
24516629-2	2014	In the rat model of hippocampal neurodegeneration obtained by Trimethyltin (TMT) administration (8 mg/kg), characterised by selective pyramidal cell loss, enhanced neurogenesis, seizures and cognitive impairment, we previously demonstrated a proliferative role of exogenous neuropeptide Y (NPY), on dentate progenitors in the early phases of neurodegeneration.	trimethyltin	62-74	neuropeptide Y	Rattus norvegicus	290-293	
24516629-2	2014	In the rat model of hippocampal neurodegeneration obtained by Trimethyltin (TMT) administration (8 mg/kg), characterised by selective pyramidal cell loss, enhanced neurogenesis, seizures and cognitive impairment, we previously demonstrated a proliferative role of exogenous neuropeptide Y (NPY), on dentate progenitors in the early phases of neurodegeneration.	trimethyltin	76-79	neuropeptide Y	Rattus norvegicus	274-288	
24516629-2	2014	In the rat model of hippocampal neurodegeneration obtained by Trimethyltin (TMT) administration (8 mg/kg), characterised by selective pyramidal cell loss, enhanced neurogenesis, seizures and cognitive impairment, we previously demonstrated a proliferative role of exogenous neuropeptide Y (NPY), on dentate progenitors in the early phases of neurodegeneration.	trimethyltin	76-79	neuropeptide Y	Rattus norvegicus	290-293	
22537092-0	2012	The neuroprotective and neurogenic effects of neuropeptide Y administration in an animal model of hippocampal neurodegeneration and temporal lobe epilepsy induced by trimethyltin.	trimethyltin	166-178	neuropeptide Y	Rattus norvegicus	46-60	
22537092-1	2012	The effects of intracerebroventricular administration of neuropeptide Y (NPY), which is believed to play an important role in neuroprotection against excitotoxicity and in the modulation of adult neurogenesis, were evaluated in an animal model of hippocampal neurodegeneration and temporal lobe epilepsy represented by trimethyltin (TMT) intoxication.	trimethyltin	319-331	neuropeptide Y	Rattus norvegicus	73-76	
22537092-1	2012	The effects of intracerebroventricular administration of neuropeptide Y (NPY), which is believed to play an important role in neuroprotection against excitotoxicity and in the modulation of adult neurogenesis, were evaluated in an animal model of hippocampal neurodegeneration and temporal lobe epilepsy represented by trimethyltin (TMT) intoxication.	trimethyltin	333-336	neuropeptide Y	Rattus norvegicus	73-76